Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Release
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Elevated Gene Expression Linked to Poor Glioblastoma Survival
Disease Discoveries

Elevated Gene Expression Linked to Poor Glioblastoma Survival

By Melissa RohmanApr 1, 2020
Share
Facebook Twitter Email
Namratha Sastry, a sixth-year student in the Northwestern University Interdepartmental Neuroscience program, was the first author of the study published in the journal Neurology-Oncology.

Northwestern Medicine investigators have found that the elevated expression of a gene called LY6K was correlated with increased cancer cell growth and resistance to radiation therapy in glioblastoma, according to findings recently published in the journal Neuro-Oncology.

LY6K is an oncogene that encodes a membrane-anchored protein, LY6K, which has the potential to promote cancer growth. This means that it may also be a potential target for treating glioblastoma via immunotherapy, according to Namratha Sastry, a sixth-year student in the Northwestern University Interdepartmental Neuroscience (NUIN) program and first author of the study.

“The precise function of LY6K is almost completely unknown — it’s thought to be involved in a couple of different cell signaling pathways, but no one really knew how it worked. My goal was to try to figure out what LY6K does in general and in cancers and cells, but also how it impacts glioblastoma survival overall,” Sastry said.

The prognosis for glioblastoma — one of the most aggressive types of brain cancer — is usually 15 to 16 months, even after treatment. Common therapeutic interventions for glioblastoma include surgery, chemotherapy, targeted drug therapy or radiation, but more biologic therapeutic approaches such as immunotherapy are slowly coming to the forefront, according to Sastry.

For the study, Sastry and the other investigators examined bioinformatic data from glioblastoma patients who had either high or low expression of LY6K. Subsequently, they examined patient-derived glioma stem-like cells and human glioblastoma cell lines, and utilized various cellular techniques to better understand the role of LY6K in glioblastoma.

Shi-Yuan Cheng, PhD, professor of Neurology in the Division of Neuro-Oncology, was the senior author of the study.

The team ultimately found that higher expression of LY6K was correlated with worse patient survival and that LY6K promotes tumorigenicity, or the progression of cells becoming cancerous.

Specifically, a pathway called the ERK1/2 signaling pathway, in which a signal on the cell membrane is transferred through a chain of proteins, can ultimately lead to changes in gene expression. LY6K then enhances the ERK1/2 signaling pathway and this is accomplished by interacting with a protein called caveolin-1. Combined, these proteins work together to enhance tumorigenicity in cells that have higher expression of LY6K, according to Sastry.

In the future, Sastry said she hopes the findings can be used to help develop novel immunotherapies that can disrupt the production of LY6K and ultimately prevent it from becoming oncogenic.

Shi-Yuan Cheng, PhD, a professor of Neurology in the Division of Neuro-Oncology, was the senior author of the study. Cheng is also a member of the Robert H. Lurie Comprehensive Cancer Center.

This work was supported by supported by National Institutes of Health (NIH) National Cancer Institute grants P30CA060553 and P50CA221747; National Institute of Neurological Diseases and Stroke grants NS095634 and F31 CA232630 (N.S.); and the Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital.

Faculty Genetics Neurology and Neuroscience Research Students
Share. Facebook Twitter Email

Related Posts

Changes in Medical School Leadership

Jan 26, 2023

Shortage of Mental Health Professionals Linked to Increase in Youth Suicides

Jan 25, 2023

Understanding How Childhood Brain Tumors Develop

Jan 23, 2023

Comments are closed.

Latest News

Changes in Medical School Leadership

Jan 26, 2023

Shortage of Mental Health Professionals Linked to Increase in Youth Suicides

Jan 25, 2023

Northwestern Medicine Scholars Program Inspires a New Generation of Physicians and Scientists 

Jan 24, 2023

Understanding How Childhood Brain Tumors Develop

Jan 23, 2023

Medical School Establishes New Center for Psychiatric Neuroscience

Jan 19, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
Feinberg_In_Vivo_20221209_tcrawford-24
Feinberg_In_Vivo_20221209_tcrawford-16
Feinberg_In_Vivo_20221209_tcrawford-14
Feinberg_In_Vivo_20221209_tcrawford-5
Feinberg_In_Vivo_20221209_tcrawford-6
Feinberg_In_Vivo_20221209_tcrawford-10
Feinberg_In_Vivo_20221209_tcrawford-8
Feinberg_In_Vivo_20221209_tcrawford-18
Feinberg_In_Vivo_20221209_tcrawford
Feinberg_In_Vivo_20221209_tcrawford-23
Feinberg_In_Vivo_20221209_tcrawford-25
Feinberg_In_Vivo_20221209_tcrawford-26

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.